NASDAQ:EDIT

Editas Medicine Stock Predictions

Healthcare > Biotechnology

Buy EDIT

*Your capital is at risk

$2.78

-0.0400 (-1.42%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

EDIT Prediction Chart

EDIT Predictions History

Latest community submissions for EDIT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Johan Oosterbaan @JohanOosterbaan.139959	Mar 5, 2020	Bullish	$25.15	X	—	1
Ibrahim Hamza @IbrahimHamza.143492	Mar 5, 2020	$20.00 -20.48%	$25.15	X	79.52%	0
Lost Virus @LostVirus.143480	Mar 5, 2020	$30.00 +19.28%	$25.15	X	80.72%	1
NameNotImportant Pro	Apr 29, 2019	$28.15 +7.16%	$26.27	X	92.84%	0
NameNotImportant Pro	Apr 24, 2019	$27.01 +0.00%	$27.01	X	100.00%	10
NameNotImportant Pro	Apr 23, 2019	$26.94 -1.82%	$27.44	X	98.18%	0
Josh.Martinez.18950	Apr 19, 2018	$39.02 +12.09%	$34.81	X	87.90%	0
Fayadosky	Mar 13, 2018	$42.92 +3.62%	$41.42	X	96.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EDIT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT EDITAS MEDICINE, INC

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, whic...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by